Investor's Business Daily on MSN49m
Why Investors Might Hammer Biogen Despite Its Earnings BeatBiogen beat fourth-quarter earnings and sales expectations Wednesday, but Biogen stock could get hammered on its light earnings outlook.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback